Skip to Content

Serine 91 Genotype of gyrA Gonorrhea Successfully Treated With Ciprofloxacin

MONDAY, Aug. 10, 2020 -- For patients with gonorrhea, detection of the wild-type serine 91 genotype of the gyrA gene of Neisseria gonorrhoeae is predictive of a successful treatment outcome with ciprofloxacin, according to a study published online Aug. 7 in Clinical Infectious Diseases.

Jeffrey D. Klausner, M.D., M.P.H., from the University of California Los Angeles, and colleagues conducted a multicenter prospective clinical study on the efficacy of a single oral dose of ciprofloxacin 500 mg in patients with culture-positive gonorrhea using a genotypic polymerase chain reaction to assess the status of the N. gonorrhoeae gyrase subunit A serine 91 codon. To determine microbiological cure at five to 10 days posttreatment, follow-up specimens were collected.

The researchers found that the efficacy of single-dose oral ciprofloxacin treatment in the per-protocol population was 100 percent among 106 individuals with culture-positive infections with the wild-type gyrA serine N. gonorrhoeae genotype.

"We found that a molecular assay to detect the wild-type serine 91 genotype of the gyrA gene of N. gonorrhoeae was highly predictive of a successful treatment outcome in subjects with gonococcal infections treated with ciprofloxacin," the authors write. "The widespread introduction and scale-up of gyrA serine 91 genotyping in N. gonorrhoeae infections could have substantial medical and public health benefits in settings where the majority of gonococcal infections are ciprofloxacin susceptible."

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Read this next

Testing for STIs in the U.S. Dropped During Early Pandemic

THURSDAY, June 3, 2021 -- Screening and testing for sexually transmitted infections (STIs) decreased in the early months of the COVID-19 pandemic, suggesting the potential for a...

Portable PCR Platform Allows Rapid Diagnosis of Gonorrhea

THURSDAY, May 27, 2021 -- A portable rapid polymerase chain reaction (PCR) platform can accurately detect Neisseria gonorrhoeae (NG), according to a study published in the May 12...

USPSTF Urges Screening Young Women for Chlamydia, Gonorrhea

WEDNESDAY, March 3, 2021 -- The U.S. Preventive Services Task Force (USPSTF) recommends screening for chlamydia and gonorrhea for all sexually active women aged 24 years and...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.